BRR : 10787955
Click Here To View Tendering Authority. Price Bid City/State :  thiruvananthapuram, Kerala
Tender Brief : Supply 187 Anti Cancer (Generic / Innovator On Demand) Drugs On Rate Contract Basis To Rcc Supply 187 Anti Cancer (Generic / Innovator On Demand) Drugs On Rate Contract Basis To Regional Cancer Centre,Thiruvananthapuram , Abiraterone Tab Ip, 250 Mg , Actinomycin D Inj, 0.5Mg/3Ml , Amifostine For Inj Usp, 500Mg , Anastrazole Tab Ip, 1Mg , Arsenic Trioxide Inj, 10 Mg , Axitinib Tab, 5 Mg , Azacitidine Inj, 100 Mg , Azacitidine Tab, 300 Mg , Bendamustine Inj Ip, 100Mg , Bevacizumab Inj., 100Mg , Bicalutamide Tab Ip, 50Mg , Bleomycin Inj Ip, 15 Units , Bortezomib Inj Ip, 2Mg , Busulphan Inj, 60 M... Read More
Tender Value
Ref. Document
Submission Date
23-05-2025
Participated Bidder List
36 No of Bidder(s)
Sr No. Bidder Name Bid Analytics Technical Bid Financial Bid AOC Bid Value Rank
1 cnet-technologies Bid Analytics 1,21,60,960 L1
2 cnet-technologies Bid Analytics L1
3 cnet-technologies Bid Analytics 3,29,00,000 L1
4 cnet-technologies Bid Analytics 1,33,12,000 L1
5 cnet-technologies Bid Analytics 13,20,000 L1
6 cnet-technologies Bid Analytics 1,93,40,000 L1
7 cnet-technologies Bid Analytics 14,40,000 L1
8 cnet-technologies Bid Analytics L1
9 cnet-technologies Bid Analytics 2,70,630 L1
10 cnet-technologies Bid Analytics 23,50,350 L1
11 cnet-technologies Bid Analytics L1
12 cnet-technologies Bid Analytics 10,00,000 L1
13 cnet-technologies Bid Analytics L1
14 cnet-technologies Bid Analytics
15 cnet-technologies Bid Analytics 34,95,425 L1
16 cnet-technologies Bid Analytics 2,76,69,375 L1
17 cnet-technologies Bid Analytics 3,95,04,000 L1
18 cnet-technologies Bid Analytics 2,19,51,448.5 L1
19 cnet-technologies Bid Analytics 1,39,10,430 L1
20 cnet-technologies Bid Analytics 6,69,600 L1
21 cnet-technologies Bid Analytics 2,37,16,515 L1
22 cnet-technologies Bid Analytics 2,38,62,400 L1
23 cnet-technologies Bid Analytics 1,72,80,000 L1
24 cnet-technologies Bid Analytics 33,48,000 L1
25 cnet-technologies Bid Analytics 27,56,660 L1
26 cnet-technologies Bid Analytics 25,74,280 L1
27 cnet-technologies Bid Analytics 3,91,300 L1
28 cnet-technologies Bid Analytics 81,23,500 L1
29 cnet-technologies Bid Analytics 2,42,51,000 L1
30 cnet-technologies Bid Analytics 3,96,96,650 L1
31 cnet-technologies Bid Analytics 87,60,006 L1
32 cnet-technologies Bid Analytics 29,14,000 L1
33 cnet-technologies Bid Analytics
34 cnet-technologies Bid Analytics 14,22,900 L1
35 cnet-technologies Bid Analytics 1,26,50,980 L1
36 cnet-technologies Bid Analytics 7,60,13,300 L1
Work Detail
supply 187 anti cancer (generic / innovator on demand) drugs on rate contract basis to rcc supply 187 anti cancer (generic / innovator on demand) drugs on rate contract basis to regional cancer centre,thiruvananthapuram , abiraterone tab ip, 250 mg , actinomycin d inj, 0.5mg/3ml , amifostine for inj usp, 500mg , anastrazole tab ip, 1mg , arsenic trioxide inj, 10 mg , axitinib tab, 5 mg , azacitidine inj, 100 mg , azacitidine tab, 300 mg , bendamustine inj ip, 100mg , bevacizumab inj., 100mg , bicalutamide tab ip, 50mg , bleomycin inj ip, 15 units , bortezomib inj ip, 2mg , busulphan inj, 60 mg , cabazitaxel inj, 60 mg with codon set , calcium leucovorin tab, 15 mg , capecitabine tab ip, 500mg , carfilzomib inj., 60mg , carmustine inj ip/usp, 100 mg , ceritinib cap, 150 mg , chlorambucil tab ip, 2mg , crizotinib cap, 250 mg , cyclophosphamide tab ip, 50mg , dacarbazine inj ip/usp, 200mg , daunorubicin inj ip, 20mg , decitabine inj, 50 mg , denosumab inj, 120mg , doxorubicin liposomal inj, 20mg , enzalutamide cap, 40 mg , eribulin inj, 0.88 mg/ml , erlotinib tab ip, 100mg , erlotinib tab ip, 150mg , etoposide cap ip, 50mg , etoposide inj ip, 100mg , everolimus tab, 5mg , exemestane tab, 25mg , filgrastim inj, 300 mcg (pfs) , filgrastim inj, 300 mcg (vial) , fludarabine phosphate inj ip / usp, 50mg , fludarabine tab, 10 mg , fulvestrant inj, 250mg , gefitinib tab ip, 250mg , hydroxy urea cap ip, 500mg , ibandronate tab, 150mg , ibandronate tab, 50mg , ibrutinib cap 140mg , idarubicin inj, 5 mg , lapatinib tab ip, 250mg , lenalidomide cap, 10mg , letrozole tab ip/usp, 2.5mg , lomustine cap ip, 40mg , megestrol acetate tab ip, 40 mg , melphalan inj ip, 50mg , melphalan tab, 5mg , mercaptopurine tab ip, 10 mg , mercaptopurine tab ip, 50 mg , mesna inj, 200mg , methotrexate inj ip, 50mg , methotrexate tab ip, 2.5mg , mitomycin inj ip, 10mg , mitoxantrone infusion bp/usp, 20mg , nilotinib cap, 200 mg , octreotide depot inj, 20mg , octreotide depot inj, 30mg , octreotide inj, 100 mcg/ml , olaparib tab, 150 mg , osimertinib tab, 80 mg , pazopanib tab, 400 mg , pegfilgrastim inj, 6mg , peg-l-asparaginase inj 750 iu/ml , pertuzumab inj, 420 mg , procarbazine hcl cap ip, 50mg , protein bound paclitaxel inj, 100mg , rasburicase inj 1.5mg , regorafenib tab 40mg , sorafenib tosylate tab ip, 200mg , tamoxifen tab ip, 20mg , tegafur +uracil cap, 100mg + 224mg , thalidomide cap 100mg , topotecan inj ip, 2.5mg , trabectedin inj, 1 mg , tretinoin cap, 10 mg , vinblastine sulphate inj ip, 10mg , vincristine sulphate inj ip/usp, 1mg , vinorelbine inj ip, 50mg , zoledronic acid inj ip, 4mg , 13-cis-retinoic acid cap, 10 mg , 13-cis-retinoic acid cap, 20 mg , 13-cis-retinoic acid cap, 40 mg , afatinib tab, 30 mg , afatinib tab, 40 mg , calcium leucovorin inj ip, 15mg , calcium leucovorin inj ip, 50mg , carboplatin inj ip, 150mg , carboplatin inj ip, 450mg , cisplatin inj ip, 10mg , cisplatin inj ip, 50mg , cyclophosphamide inj ip, 200mg , cyclophosphamide inj ip, 500mg , cytarabine inj ip/bp, 1 gm , cytarabine inj ip/bp, 100mg , dasatinib tab, 20mg , dasatinib tab, 50mg , docetaxel inj ip, 120mg , docetaxel inj ip, 20mg , docetaxel inj ip, 80mg , doxorubicin inj (lyophilised) ip, 10mg , doxorubicin inj (lyophilised) ip, 50mg , epirubicin inj bp/usp, 10mg , epirubicin inj bp/usp, 50mg , flurouracil inj ip, 250mg , flurouracil inj ip, 500mg , gemcitabine inj ip, 200mg , gemcitabine inj ip, 1gm , ifosfamide with mesna inj, 1gm , ifosfamide with mesna inj, 2gm , imatinib tab ip, 100mg , imatinib tab ip, 400 mg , irinotecan inj ip, 100mg , irinotecan inj ip, 40mg , l.asparaginase inj, 10000 iu , leuprolide acetate inj, 11.25mg , leuprolide acetate inj, 22.5mg , leuprolide acetate inj, 3.75mg , methotrexate inj ip, 1 gm , methotrexate inj ip, 500 mg , oxaliplatin inj ip, 100mg , oxaliplatin inj ip, 50mg , paclitaxel inj ip, 30mg , paclitaxel inj ip with codon set, 100mg , paclitaxel inj ip with codon set, 260mg , pemetrexed inj ip, 100mg , pemetrexed inj ip., 500mg , pomalidomide cap, 2 mg , pomalidomide cap, 4 mg , rituximab inj, 500mg , rituximab inj., 100mg , sunitinib cap, 25 mg , sunitinib cap, 50 mg , temozolomide cap ip, 100mg , temozolomide cap ip, 20mg , temozolomide cap ip, 250mg , trastuzumab emtansine 100mg , trastuzumab emtansine 160mg , trastuzumab inj, 150 mg , trastuzumab inj., 440mg , degarelix inj, 120 mg , degarelix inj, 80 mg , lenvatinib cap, 10 mg , lenvatinib cap, 4 mg , palbociclib tab, 100 mg , palbociclib tab, 125 mg , palbociclib tab, 75 mg , abemaciclib tab 150 mg , alectinib tab, 150 mg , alpelisib tab 150 mg , atezolizumab inj, 1200 mg/ 20ml , bevacizumab inj, 100mg , capecitabine tab ip, 500mg , cetuximab inj, 100mg , cladribine inj, 10mg , cytarabine inj ip/bp, 1 gm , cytarabine inj ip/bp, 100mg , daratumumab inj, 100mg/5ml , daratumumab inj, 400mg/20ml , daratumumab inj, 1800mg for subcutaneous , daunorubicin inj ip, 20mg , doxorubicin inj (lyophilised) ip, 10mg , doxorubicin inj (lyophilised) ip, 50mg , goserelin 10.8 mg inj , letrozole tab ip/usp, 2.5mg , nimotuzumab inj, 200 mg , nivolumab inj, 10 mg/ml , nivolumab inj, 40 mg , olaparib tab, 150 mg , osimertinib tab, 80 mg , palbociclib tab, 100 mg , palbociclib tab, 125 mg , panitumumab inj, 100 mg , pembrolizumab inj, 100mg , pertuzumab inj, 420 mg , ramucirumab inj 500mg/5 ml , ribociclib tab, 200 mg , rituximab inj, 100mg , rituximab inj, 500mg , trastuzumab emtansine inj, 100 mg , trastuzumab emtansine inj, 160 mg
View Original Notice/Document
Result Documents
Tender Documents
Download File Name File Description
Download 745c50d6-2754-4c2a-8a00-2316f103b986 financialevaluation notice
Download boqcomparativechart boq document
Download finance_1243121 aoc document
Download finsummary_1243121 aoc document
Download File Name File Description
Download 51c73952-ecff-4394-8eaf-59613d4109d0 Tender Documents
Download BOQ_1243121 Tender Documents
Download CompACD187 Tender Documents
Download Tendernotice_1 Tender Documents
Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

Financial Evaluation In Progress

Financial bids are currently under review. Awarded bidder information will be published after final evaluation.

PriceBid
Similar Tenders Results
TenderDetail
Loading tenders